This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cci Corporation. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations of Tadashi Tomo in Peritoneal Membrane Treatment.
Introduction
Tadashi Tomo is a notable inventor based in Oita, Japan. He has made significant contributions to the field of medical technology, particularly in the treatment of peritoneal membrane thickening. His work focuses on developing solutions that mitigate adverse effects associated with this condition.
Latest Patents
Tadashi Tomo holds a patent for an agent aimed at inhibiting peritoneal membrane thickening. This invention is designed to enable the prevention or treatment of thickening in the peritoneal membrane. The patent describes a dialysis fluid that incorporates a thickening inhibitory agent, which includes a chromanol glycoside as its effective ingredient.
Career Highlights
Tadashi Tomo is associated with Cci Corporation, where he continues to innovate in the medical field. His work has been instrumental in addressing challenges related to peritoneal dialysis and improving patient outcomes.
Collaborations
Tadashi Tomo collaborates with Hironobu Murase, contributing to advancements in their shared field of expertise.
Conclusion
Tadashi Tomo's innovative work in developing agents for inhibiting peritoneal membrane thickening showcases his commitment to improving medical treatments. His contributions are vital for enhancing the quality of life for patients undergoing dialysis.